Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Gastroenterology Clinics of North America|May 17, 2023
Global Impact of ObesityNasreen Alfaris, Ali Mohammed Alqahtani, Naji Alamuddin, et al.
Eclinicalmedicine|September 16, 2024
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative reviewNasreen Alfaris, Stephanie Waldrop, Veronica Johnson, et al.
Expert Opinion on Pharmacotherapy|May 12, 2015
Combination phentermine and topiramate extended release in the management of obesityNasreen Alfaris, Alyssa M Minnick, Christina M Hopkins, et al.
Diabetes, Obesity & Metabolism|June 16, 2026
Tirzepatide for Obesity in Adults ≥ 65 Years: A Post Hoc Analysis of the SURMOUNT and SUMMIT Clinical TrialsNasreen Alfaris, Robert F Kushner, Jianghao Li, et al.
Frontiers in Psychology|August 18, 2018
"Last Supper" Predicts Greater Weight Loss Early in Obesity Treatment, but Not Enough to Offset Initial GainsJena Shaw Tronieri, Thomas A Wadden, Nasreen Alfaris, et al.
SAGE Open Medicine|January 28, 2025
Experiences and overall impact reported by people living with obesity: results from a multinational studyEsther Artime, Swarna Khare, Sarah Zimner-Rapuch, et al.
Contemporary Clinical Trials|June 11, 2017
Lorcaserin plus lifestyle modification for weight loss maintenance: Rationale and design for a randomized controlled trialJena Shaw Tronieri, Nasreen Alfaris, Ariana M Chao, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 18, 2016
The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center studyFatima Cody Stanford, Nasreen Alfaris, Gricelda Gomez, et al.
BMC Gastroenterology|June 2, 2021
Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver diseaseSaleh A Alqahtani, Dieter C Broering, Saad A Alghamdi, et al.
Pageof 2